Ehrenwald E, Chisolm G M, Fox P L
Department of Cell Biology, Cleveland Clinic Research Institute, Ohio 44195.
J Clin Invest. 1994 Apr;93(4):1493-501. doi: 10.1172/JCI117127.
Ceruloplasmin is a plasma protein that carries most of the copper found in the blood. Although its elevation after inflammation and trauma has led to its classification as an acute phase protein, its physiological role is uncertain. A frequently reported activity of ceruloplasmin is its ability to suppress oxidation of lipids. In light of the intense recent interest in the oxidation of plasma LDL, we investigated the effects of ceruloplasmin on the oxidation of this lipoprotein. In contrast to our expectations, highly purified, undegraded human ceruloplasmin enhanced rather than suppressed copper ion-mediated oxidation of LDL. Ceruloplasmin increased the oxidative modification of LDL as measured by thiobarbituric acid-reacting substances by at least 25-fold in 20 h, and increased electrophoretic mobility, conjugated dienes, and total lipid peroxides. In contrast, ceruloplasmin that was degraded to a complex containing 115- and 19-kD fragments inhibited cupric ion oxidation of LDL, as did commercial preparations, which were also degraded. However, the antioxidant capability of degraded ceruloplasmin in this system was similar to that of other proteins, including albumin. The copper in ceruloplasmin responsible for oxidant activity was not removed by ultrafiltration, indicating a tight association. Treatment of ceruloplasmin with Chelex-100 removed one of seven copper atoms per molecule and completely blocked oxidant activity. Restoration of the copper to ceruloplasmin also restored oxidant activity. These data indicate that ceruloplasmin, depending on the integrity of its structure and its bound copper, can exert a potent oxidant rather than antioxidant action on LDL. Our results invite speculation that ceruloplasmin may be in part responsible for oxidation of LDL in blood or in the arterial wall and may thus have a physiological role that is quite distinct from what is commonly believed.
铜蓝蛋白是一种血浆蛋白,它携带血液中发现的大部分铜。尽管炎症和创伤后其水平升高使其被归类为急性期蛋白,但其生理作用尚不确定。铜蓝蛋白经常被报道的一项活性是其抑制脂质氧化的能力。鉴于近期人们对血浆低密度脂蛋白(LDL)氧化的浓厚兴趣,我们研究了铜蓝蛋白对这种脂蛋白氧化的影响。与我们的预期相反,高度纯化、未降解的人铜蓝蛋白增强而非抑制了铜离子介导的LDL氧化。通过硫代巴比妥酸反应物质测定,铜蓝蛋白在20小时内使LDL的氧化修饰增加了至少25倍,并增加了电泳迁移率、共轭二烯和总脂质过氧化物。相比之下,降解为含有115-kD和19-kD片段的复合物的铜蓝蛋白抑制了LDL的铜离子氧化,市售制剂也是如此,它们也被降解了。然而,在这个系统中,降解的铜蓝蛋白的抗氧化能力与其他蛋白质(包括白蛋白)相似。负责氧化活性的铜蓝蛋白中的铜不能通过超滤去除,这表明两者紧密结合。用Chelex-100处理铜蓝蛋白可去除每个分子七个铜原子中的一个,并完全阻断氧化活性。将铜恢复到铜蓝蛋白中也恢复了氧化活性。这些数据表明,铜蓝蛋白根据其结构完整性和结合的铜,可对LDL发挥强大的氧化而非抗氧化作用。我们的结果引发了这样的推测,即铜蓝蛋白可能在一定程度上导致血液或动脉壁中LDL的氧化,因此可能具有与普遍认知截然不同的生理作用。